Novartis Ag (NVS) Receivables - Net (2009 - 2026)
Novartis Ag's Receivables - Net was $9.64 billion in Q2 2026, up 6.4% from $9.06 billion a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Novartis Ag came in at $8.94 billion, up 20.4% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $7.42 billion in FY2024 (+4.4%), $7.11 billion in FY2023 (-11.9%), $8.07 billion in FY2022 (+0.8%) and $8.01 billion in FY2021 (-2.6%).
- The Q2 2026 figure marks the highest quarterly Receivables - Net since Q1 2014.
- Compared with a year earlier, Receivables - Net has increased for eight straight quarters, with growth averaging 11.0% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2025 (growth of 20.4%); the worst was Q3 2023 (a decline of 19.0%).
- Per Business Quant data, NVS's Receivables - Net in the three quarters before Q2 2026 was $9.39 billion (Q1 2026), $8.94 billion (Q4 2025) and $8.84 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.64 Bn |
| Mar 31, 2026 | 9.39 Bn |
| Dec 31, 2025 | 8.94 Bn |
| Sep 30, 2025 | 8.84 Bn |
| Jun 30, 2025 | 9.06 Bn |
| Mar 31, 2025 | 8.60 Bn |
| Dec 31, 2024 | 7.42 Bn |
| Sep 30, 2024 | 7.97 Bn |
| Jun 30, 2024 | 8.23 Bn |
| Mar 31, 2024 | 7.84 Bn |
| Dec 31, 2023 | 7.11 Bn |
| Sep 30, 2023 | 6.82 Bn |
| Jun 30, 2023 | 9.20 Bn |
| Mar 31, 2023 | 8.92 Bn |
| Dec 31, 2022 | 8.07 Bn |
| Sep 30, 2022 | 8.42 Bn |
| Jun 30, 2022 | 8.64 Bn |
| Mar 31, 2022 | 8.41 Bn |
| Dec 31, 2021 | 8.01 Bn |
| Sep 30, 2021 | 8.38 Bn |
API Access
Novartis Ag Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();